Skip to content
Lab Tests Dubai
Immunology Tests

Anti-Acetylcholine Receptor Antibodies (Myasthenia Gravis)

Anti-Acetylcholine Receptor Antibodies (Myasthenia Gravis) at Lab Tests Dubai costs AED 1,150 (VAT included), uses a serum sample and results are usually ready in 10 days. Book home collection across Dubai for AED 150 per visit or visit our Al Karama lab — no doctor referral needed.

Key facts

Price (incl. VAT)
AED 1,150
Sample
Serum
Method
Radioimmunoassay
Results in
10 days
Home collection
AED 150 per visit
Doctor referral
Not needed

The Anti-Acetylcholine Receptor Antibody Test from Lab Tests Dubai is a specialized blood test that detects autoantibodies targeting acetylcholine receptors (AChR) at the neuromuscular junction, key to diagnosing Myasthenia Gravis (MG), a rare but treatable autoimmune neuromuscular disorder.

In MG, the immune system attacks AChR proteins, disrupting nerve-to-muscle communication and causing fluctuating muscle weakness that worsens with activity and improves with rest.

This test is essential for:

  • Diagnosing generalized or ocular Myasthenia Gravis
  • Evaluating unexplained ptosis (drooping eyelids) or diplopia (double vision)
  • Investigating progressive limb or respiratory muscle weakness
  • Monitoring treatment response in confirmed MG patients

Using high-sensitivity radioimmunoassay (RIA) or cell-based assays, this serum test delivers accurate results within 10 days, helping neurologists confirm or rule out MG, so patients can get life-changing treatment faster.

Available with home blood collection, Lab Tests Dubai ensures accurate, private, and stress-free testing, so you can get answers without disruption to your care.

Why You Need This Test

If you’re struggling with drooping eyelids, double vision, or muscle fatigue that gets worse as the day goes on, this test could reveal a treatable neurological condition.

You need the Anti-AChR Antibody Test if:

  • You have ptosis (drooping eyelids) that fluctuates during the day
  • You experience double vision (diplopia) when tired
  • Your arms or legs weaken with use but improve with rest
  • You have difficulty swallowing, speaking, or chewing
  • You suffer from shortness of breath or weak cough (risk of myasthenic crisis)
  • You’ve had negative EMG or normal MRI but symptoms persist
  • You’re being evaluated for autoimmune or neurological disorders

This test helps:

  • Confirm Myasthenia Gravis (positive in ~85% of generalized MG)
  • Rule out mimics like ALS, Lambert-Eaton syndrome, or thyroid eye disease
  • Guide treatment with immunosuppressants or thymectomy

Early diagnosis = prevention of respiratory crisis and improved quality of life.

Symptoms That Indicate This Test

Consider the AChR Antibody Test if you experience:

  • Ocular Symptoms (Most Common Initial Signs):

  • Drooping eyelids (ptosis) – worse in evening

  • Double vision (diplopia) – improves with rest

  • Difficulty keeping eyes open

  • Generalized Muscle Weakness:

  • Arm/leg fatigue when lifting or climbing

  • Head drop due to weak neck muscles

  • Slurred speech (dysarthria) after talking

  • Difficulty swallowing (dysphagia) – choking on liquids

  • Respiratory Involvement (Medical Emergency):

  • Shortness of breath

  • Weak cough or inability to clear secretions

  • Myasthenic crisis – acute respiratory failure

  • For Thymus-Related Risk:

  • Thymoma on chest imaging

  • Young women with autoimmune disorders

These signs may point to Myasthenia Gravis, and this test provides critical diagnostic clarity.

Natural Production: How Autoantibodies Disrupt Muscle Function

Acetylcholine (ACh) is a neurotransmitter released by motor nerves to stimulate muscle contraction at the neuromuscular junction.

In healthy individuals:

  • ACh binds to acetylcholine receptors (AChR) on muscle cells
  • Signal is transmitted → muscle contracts

In Myasthenia Gravis:

  • Immune system produces IgG autoantibodies against AChR
  • Antibodies block, internalize, or destroy receptors
  • Fewer receptors = weaker signal transmission
  • Result: muscle fatigue and weakness

Key Facts

  • 85% of generalized MG patients are AChR antibody positive
  • 50% of ocular MG (only eye symptoms) are positive
  • Associated with thymic abnormalities (hyperplasia or thymoma)

This test detects binding, modulating, or blocking antibodies, with high specificity for MG.

What Happens If Untreated? Risks of Ignoring Myasthenia Gravis

Ignoring MG symptoms can lead to:

  • Myasthenic Crisis – life-threatening respiratory failure requiring ICU care
  • Aspiration Pneumonia – from swallowing difficulties
  • Progressive Disability – inability to walk, speak, or eat
  • Thymoma Progression – if thymus tumor is present
  • Reduced Quality of Life – social isolation, depression

The good news? MG is highly treatable with:

  • Acetylcholinesterase inhibitors (e.g., pyridostigmine)
  • Immunosuppressants (steroids, azathioprine, rituximab)
  • Plasmapheresis or IVIG for crises
  • Thymectomy (if thymoma or generalized MG)

Early testing = faster treatment and better outcomes.

How to Prepare for the Test

To ensure accurate results:

  • No fasting required

  • Continue your regular medications, but inform your doctor

  • Avoid neuromuscular-blocking drugs or IVIG before testing (can affect results)

  • Inform your doctor of:

  • Current symptoms and triggers

  • Recent infections or surgeries

  • Use of cholinesterase inhibitors (e.g., Mestinon)

A serum blood sample is collected via standard draw, available at our labs or via home collection.

Test Overview: Radioimmunoassay Method

Test Name Anti-Acetylcholine Receptor Antibodies (AChR)
Sample Type Serum (Blood)
Methodology Radioimmunoassay (RIA) or Cell-Based Assay
Turnaround Time (TAT) 10 Days
Category Immunology / Neurological Diagnostics
Purpose Diagnose Myasthenia Gravis, evaluate neuromuscular weakness
Testing Location Lab Tests Dubai – Accredited Labs & Home Collection Across UAE

Interpretation

Note: Up to 15% of generalized MG patients are seronegative, additional tests (anti-MuSK, anti-LRP4) may be needed.

Benefits of the Anti-AChR Antibody Test

  • Early Diagnosis of MG

Stop misdiagnosis and start treatment sooner.

  • Avoid Unnecessary Procedures

Rule out ALS, stroke, or thyroid disease.

  • Guide Treatment Decisions

Determine need for thymectomy or immunosuppression.

  • Monitor Disease Activity

Track antibody levels during therapy.

  • Peace of Mind

Get answers for chronic, unexplained weakness.

If you’re tired of drooping eyes, double vision, or muscles that give out, the Anti-Acetylcholine Receptor Antibody Testgives you the answers you need in 10 days.

Frequently asked questions

What does this test measure?

This blood test detects autoantibodies against acetylcholine receptors (AChR), proteins essential for nerve-to-muscle communication. These antibodies are a hallmark of Myasthenia Gravis (MG), an autoimmune disorder that causes muscle weakness by blocking or destroying AChRs at the neuromuscular junction.

When should I get tested?

Consider this test if you experience: – Drooping eyelids (ptosis) that worsen with fatigue – Double vision (diplopia) – Difficulty swallowing, chewing, or speaking – Arm or leg weakness that improves with rest – Shortness of breath or weak cough (signs of respiratory involvement) It’s also used to confirm MG before starting immunosuppressive therapy or thymectomy.

How accurate is this test for diagnosing MG?

The test is highly specific (>99%) for MG. It’s positive in: – ~85% of patients with generalized MG – ~50% of those with ocular MG (eye symptoms only) A negative result doesn’t rule out MG, some patients are “seronegative” and may need additional tests (e.g., anti-MuSK, anti-LRP4).

Do I need to fast before the test?

No fasting is required. You can eat and drink normally. Continue your regular medications unless instructed otherwise by your neurologist. Inform your provider if you’ve recently received IVIG or plasmapheresis, as these can temporarily lower antibody levels.

How soon will I get my results?

Due to specialized radioimmunoassay (RIA) methodology, results typically take 10 business days. You’ll receive a detailed report indicating your AChR antibody level (in nmol/L) and clinical interpretation.

Can this test monitor treatment response?

Yes. Declining AChR antibody levels often correlate with clinical improvement during immunosuppressive therapy. Your neurologist may repeat the test every 6–12 months to assess disease activity and guide treatment adjustments.

Explore more tests

Book this test

No doctor referral needed. Home sample collection in Dubai for AED 150 per visit, or visit our lab in Al Karama. Every price includes VAT.